IARC Monographs Volume 100F
Benzene

Supplementary Web Tables, Section 1, Exposure Data and Section 2, Cancer in Humans

  These web tables formed part of the original submission and have been peer reviewed. They
  are posted as supplied by the Working Group. Readers are requested to report any errors to:
  edit-vol100F@iarc.fr.
Table 1.2   Summary of airborne benzene concentrations from petroleum based solvent products containing trace levels of benzene
Table 2.1   Cohort studies of benzene and acute non-lymphocytic leukemia/acute myelogenous leukemia
Table 2.2   Case–control studies of benzene and acute non-lymphocytic leukemia/acute myelogenous leukemia
Table 2.3   Cohort studies of exposure to benzene and the risk for acute lymphoblastic leukaemia (ALL)
Table 2.4   Case–control studies of exposure to benzene and the risk for acute lymphocytic leukaemia (ALL)
Table 2.5   Cohort studies of benzene and the chronic myeloid leukemia
Table 2.6   Case–control studies of benzene and the chronic myeloid leukemia
Table 2.7   Cohort studies of exposure to benzene and the risk for chronic lymphocytic leukaemia (CLL)
Table 2.8   Case–control studies of exposure to benzene and chronic lymphatic leukaemia
Table 2.9   Cohort studies of exposure to benzene and the risk for non-Hodgkin lymphoma (NHL)
Table 2.10   Case–control studies of exposure to benzene and non-Hodgkin lymphoma
Table 2.11   Cohort studies of exposure to benzene and the risk for multiple myeloma
Table 2.12   Case–control studies of exposure to benzene and multiple myeloma
Table 2.13   Cohort studies of benzene and Hodgkin’s disease
Table 2.14   Case–control studies of benzene and Hodgkin’s disease
Table 2.15   Cohort studies of benzene and lung cancer
Table 2.16   Case–control study of benzene and lung cancer
Table 2.17   Cohort studies of benzene and kidney cancer
Table 2.18   Case–control studies of benzene and kidney cancer